Clinical trial
Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling
NCT02654236 is registered in ClinicalTrials.gov with Suthat Liangpunsakul as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling
- Lead sponsor
- Suthat Liangpunsakul
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- September 30, 2019
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol consumption